Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-25 5:04 pm Sale | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 19.8% | -1,292,408 (-28.88%) | View |
| 2019-11-07 5:24 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 2,290,490 10% | 2,290,490 (New Position) | View |
| 2019-05-06 5:01 pm Purchase | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 4,475,722 31.6% | 1,938,612 (+76.41%) | View |